Entries by CAPTIS

Abbott wins Aetna nod for Proclaim neurostim in chronic pain

Abbott (NYSE:ABT) said today that it won a reimbursement nod from Aetna (NYSE:AET) for its Proclaim dorsal root ganglion neurostimulation therapy for treating chronic pain. The national coverage decision opens DRG treatment to some 22 million Aetna members, Abbott said. Aetna already covers treatment with Abbott’s spinal cord stimulation devices, the company said. It acquired […]

Medtronic can’t shake shareholder suit over Covidien merger

A Minnesota state court last week gave a group of Medtronic (NYSE:MDT) shareholders another chance at a lawsuit brought over its $50 billion acquisition of Covidien. In early 2015 Medtronic closed the Covidien deal, consummating in the biggest medical device acquisition ever. Shortly after the deal was announced during the summer of 2014, shareholder Lewis Merenstein sued in Minnesota’s […]

Certain polyethylene-lined hips may last longer than others

The DePuy Marathon total hip, made with a highly cross-linked polyethylene liner Researchers in New Zealand found that artificial hip liners made of highly-cross-linked polyethylene showed less wear 10 years after implantation than liners made of conventional ultra-high-molecular-weight polyethylene. Patients whose hip liners were made of highly cross-linked polyethylene also had a significantly lower prevalence […]

Exosome therapeutics dev Evox raises $45m in Series B

Exosome therapeutics company Evox Therapeutics said today that it raised $45.4 million (GBP £35.5 million) in a Series B round of financing. The funding round was led by Redmile Group, new investments from GV, formerly known as Google Ventures, and Cowen Healthcare Investments, the Oxford, U.K.-based company said. The round was joined by Panacea Healthcare […]

Inovio launches Ph1 study of Hep C vaccine

Inovio Pharmaceuticals (NSDQ:INO) and its partner, GeneOne Life Science (KSE:011000), said today that the companies have dosed the first patient in a Phase I study designed to test a preventive vaccine against hepatitis C infection. The companies plan to recruit 24 study participants to evaluate Inovio’s GLS-6150 candidate. Participants will include people who have a sustained […]

Egypt CAPA expands medical device oversight regulations

By Stewart Eisenhart, Emergo Group Expanded medical device registration requirements in Egypt remain set to come into effect September 1, 2018, but affected companies should be familiarizing themselves now with new Central Administration of Pharmaceutical Affairs (CAPA) processes. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post […]

Magnolia Medical launches Sterpaith Gen2 system

Magnolia Medical Technologies said yesterday it launched its Steripath Gen2 blood collection system. The next-generation device features mechanical initial specimen diversion and improved usability based on input from end users, the Seattle-based company said. “Our team is very pleased with the 83 percent reduction in blood culture contamination we have achieved using Steripath. Based on this […]

Ortho start-up Embody raises $2m

Orthopedic-focused medtech startup Embody raised $1.5 million to help support its tendon and ligament-treating products, according to a Hampton Roads Business Journal report. The round was led by 757 Angels and the Center for Innovative Technology, according to the report. Embody is using proprietary manufacturing techniques to produce advanced collagen matrices intended for use in tendon […]

BlueWind posts positive follow-up study results

BlueWind Medical’s implantable tibial stimulation device Neurostim developer BlueWind Medical reported positive results from a follow-up study of patients using its implantable tibial nerve stimulator for overactive bladder (OAB). Renova iStim is a leadless, miniature, wireless neurostimulation platform designed for the treatment of multiple clinical indications. Three years after implantation of the BlueWind’s Renova iStim device, 75% of […]